BSP - Biological Signal Processing

About

Q&A

What is the primary focus of BSP - Biological Signal Processing?

BSP - Biological Signal Processing focuses on the noninvasive diagnosis and monitoring of ischemic heart disease.

What is the status of BSP - Biological Signal Processing?

BSP - Biological Signal Processing is currently inactive, as of May 2018.

What product line does BSP - Biological Signal Processing offer?

The company offers the HyperQ line of products, which are based on patented high-frequency technology for stress and resting ECG tests.

What are the applications of the HyperQ product line?

The HyperQ Stress improves diagnosis for patients suspected of coronary artery disease, while HyperQ Rest helps emergency departments detect acute coronary syndrome.

Where has the HyperQ technology been clinically validated?

Numerous trials and clinical studies have been conducted with thousands of patients in Israel, Europe, Asia, and the United States, confirming the diagnostic value of HyperQ technology.

When was BSP - Biological Signal Processing founded?

BSP - Biological Signal Processing was founded in January 2000.

How many employees does BSP - Biological Signal Processing have?

BSP - Biological Signal Processing has 1-10 employees.

In which sector does BSP - Biological Signal Processing primarily operate?

The company's primary sector is Health Tech & Life Sciences, specifically focusing on Medical Devices and Diagnostics Devices.

Team · 1

Amir Beker

Founder · Founder

LinkedIn ↗

Sectors & technology

Highlights

Tags